Quantinno Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Quantinno Capital Management's IMVT Position: Q3 2026 in Review
Quantinno Capital Management increased its Immunovant (IMVT) stake by 4.7% in Q3 2026, buying an estimated $85.9K and bringing the position to 48,185 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2377.
Quantinno Capital Management first reported a position in IMVT in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.77M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Quantinno Capital Management held 48,185 shares of Immunovant worth $1.63M as of Q3 2026.
- Quantinno Capital Management bought 2,180 Immunovant shares in Q3 2026, an estimated $85.9K.
- Immunovant made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2377 holding.
- Quantinno Capital Management first reported a position in Immunovant in Q3 2025 and has held it in 5 quarters since.
- Quantinno Capital Management's Immunovant position peaked at $1.77M in Q2 2026.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.